700 related articles for article (PubMed ID: 19628492)
1. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
[TBL] [Abstract][Full Text] [Related]
2. VEGF polymorphisms are associated with severity of diabetic retinopathy.
Churchill AJ; Carter JG; Ramsden C; Turner SJ; Yeung A; Brenchley PE; Ray DW
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3611-6. PubMed ID: 18441306
[TBL] [Abstract][Full Text] [Related]
3. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
Lee SJ; Choi MG
Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
[TBL] [Abstract][Full Text] [Related]
4. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
[TBL] [Abstract][Full Text] [Related]
5. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
[TBL] [Abstract][Full Text] [Related]
6. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
7. Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy.
Iizuka H; Awata T; Osaki M; Neda T; Kurihara S; Inoue K; Inukai K; Kabasawa S; Mori K; Yoneya S; Katayama S
Biochem Biophys Res Commun; 2007 Sep; 361(2):421-6. PubMed ID: 17658465
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
Lee SJ; Choi MG; Kim DS; Kim TW
Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.
Buraczynska M; Baranowicz-Gaszczyk I; Tarach J; Ksiazek A
Hum Immunol; 2009 Feb; 70(2):121-4. PubMed ID: 19135114
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients.
Tsai YY; Chiang CC; Bau DT; Cheng YW; Lee H; Tseng SH; Tsai FJ
Cornea; 2008 May; 27(4):476-9. PubMed ID: 18434853
[TBL] [Abstract][Full Text] [Related]
12. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
13. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
[TBL] [Abstract][Full Text] [Related]
15. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
17. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
18. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
[TBL] [Abstract][Full Text] [Related]
19. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis.
Qiu M; Xiong W; Liao H; Li F
Gene; 2013 Apr; 518(2):310-5. PubMed ID: 23353010
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]